MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $250,000 | -59.8% | 201,900 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $622,000 | -24.5% | 201,900 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $824,000 | -30.1% | 201,900 | +8.8% | 0.00% | -50.0% |
Q3 2016 | $1,179,000 | +17.9% | 185,600 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,000,000 | -29.7% | 185,600 | +5.5% | 0.00% | -33.3% |
Q1 2016 | $1,423,000 | +31.5% | 176,000 | +28.6% | 0.00% | 0.0% |
Q4 2015 | $1,082,000 | -7.1% | 136,900 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,165,000 | -20.1% | 136,900 | +16.1% | 0.00% | -25.0% |
Q2 2015 | $1,458,000 | +6.5% | 117,900 | +2.3% | 0.00% | 0.0% |
Q1 2015 | $1,369,000 | +8.8% | 115,200 | +3.5% | 0.00% | -20.0% |
Q4 2014 | $1,258,000 | +28.8% | 111,300 | 0.0% | 0.01% | +25.0% |
Q3 2014 | $977,000 | +20.5% | 111,300 | 0.0% | 0.00% | +33.3% |
Q2 2014 | $811,000 | +44.6% | 111,300 | 0.0% | 0.00% | +50.0% |
Q1 2014 | $561,000 | +13.8% | 111,300 | +20.5% | 0.00% | 0.0% |
Q4 2013 | $493,000 | +40.5% | 92,400 | 0.0% | 0.00% | +100.0% |
Q3 2013 | $351,000 | -39.2% | 92,400 | +7.7% | 0.00% | -66.7% |
Q2 2013 | $577,000 | – | 85,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |